Demographics and Comorbidities of Interview Participants Diagnosed With Mpox (May–October 2022), Seattle–King County, Washingtona
| Demographics and Comorbidities . | N = 115 . |
|---|---|
| Age, y, median (IQR) | 36 (29–42) |
| Race/ethnicity, No. (%) | |
| Non-Hispanic White | 58 (50.4) |
| Hispanic/Latinx | 26 (22.6) |
| Multiple races | 17 (14.8) |
| Black or African American | n ≤ 10 (7.8) |
| Asian or South Asian | n ≤ 10 (4.3) |
| Education. No. (%) | |
| Less than high school | n ≤ 10 (0.9) |
| High school diploma | 14 (12.2) |
| Trade school certificate | n ≤ 10 (7.0) |
| Community college or university degree | 63 (54.8) |
| Graduate degree | 25 (21.7) |
| Other | n ≤ 10 (3.5) |
| Gender, No. (%) | |
| Cisgender male | 103 (89.6) |
| Gender diverseb | 12 (10.4) |
| Sexual partners (not mutually exclusive), No. (%) | |
| Cisgender male | 110 (95.7) |
| Transgender male | 12 (10.4) |
| Nonbinary/genderqueer | 10 (8.7) |
| Cisgender female | n ≤ 10 (5.2) |
| Transgender female | n ≤ 10 (4.3) |
| Other | n ≤ 10 (3.5) |
| Comorbidities, No. (%) | |
| None of the below comorbidities | 53 (46.9) |
| HIV | 38 (33.6) |
| CD4 count ≥200 cells/μL | 18 (47.3) |
| CD4 count <200 cells/μL | 2 (5.2) |
| CD4 count unknown | 18 (47.3) |
| Eczema/psoriasis | 13 (11.5) |
| Heart disease | n ≤ 10 (3.5) |
| Diabetes | n ≤ 10 (1.8) |
| Cancer | n ≤ 10 (1.8) |
| Demographics and Comorbidities . | N = 115 . |
|---|---|
| Age, y, median (IQR) | 36 (29–42) |
| Race/ethnicity, No. (%) | |
| Non-Hispanic White | 58 (50.4) |
| Hispanic/Latinx | 26 (22.6) |
| Multiple races | 17 (14.8) |
| Black or African American | n ≤ 10 (7.8) |
| Asian or South Asian | n ≤ 10 (4.3) |
| Education. No. (%) | |
| Less than high school | n ≤ 10 (0.9) |
| High school diploma | 14 (12.2) |
| Trade school certificate | n ≤ 10 (7.0) |
| Community college or university degree | 63 (54.8) |
| Graduate degree | 25 (21.7) |
| Other | n ≤ 10 (3.5) |
| Gender, No. (%) | |
| Cisgender male | 103 (89.6) |
| Gender diverseb | 12 (10.4) |
| Sexual partners (not mutually exclusive), No. (%) | |
| Cisgender male | 110 (95.7) |
| Transgender male | 12 (10.4) |
| Nonbinary/genderqueer | 10 (8.7) |
| Cisgender female | n ≤ 10 (5.2) |
| Transgender female | n ≤ 10 (4.3) |
| Other | n ≤ 10 (3.5) |
| Comorbidities, No. (%) | |
| None of the below comorbidities | 53 (46.9) |
| HIV | 38 (33.6) |
| CD4 count ≥200 cells/μL | 18 (47.3) |
| CD4 count <200 cells/μL | 2 (5.2) |
| CD4 count unknown | 18 (47.3) |
| Eczema/psoriasis | 13 (11.5) |
| Heart disease | n ≤ 10 (3.5) |
| Diabetes | n ≤ 10 (1.8) |
| Cancer | n ≤ 10 (1.8) |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range.
aSmall cell sizes ≤10 are suppressed.
bGender diverse includes nonbinary/genderqueer, transgender men and women, and other.
Demographics and Comorbidities of Interview Participants Diagnosed With Mpox (May–October 2022), Seattle–King County, Washingtona
| Demographics and Comorbidities . | N = 115 . |
|---|---|
| Age, y, median (IQR) | 36 (29–42) |
| Race/ethnicity, No. (%) | |
| Non-Hispanic White | 58 (50.4) |
| Hispanic/Latinx | 26 (22.6) |
| Multiple races | 17 (14.8) |
| Black or African American | n ≤ 10 (7.8) |
| Asian or South Asian | n ≤ 10 (4.3) |
| Education. No. (%) | |
| Less than high school | n ≤ 10 (0.9) |
| High school diploma | 14 (12.2) |
| Trade school certificate | n ≤ 10 (7.0) |
| Community college or university degree | 63 (54.8) |
| Graduate degree | 25 (21.7) |
| Other | n ≤ 10 (3.5) |
| Gender, No. (%) | |
| Cisgender male | 103 (89.6) |
| Gender diverseb | 12 (10.4) |
| Sexual partners (not mutually exclusive), No. (%) | |
| Cisgender male | 110 (95.7) |
| Transgender male | 12 (10.4) |
| Nonbinary/genderqueer | 10 (8.7) |
| Cisgender female | n ≤ 10 (5.2) |
| Transgender female | n ≤ 10 (4.3) |
| Other | n ≤ 10 (3.5) |
| Comorbidities, No. (%) | |
| None of the below comorbidities | 53 (46.9) |
| HIV | 38 (33.6) |
| CD4 count ≥200 cells/μL | 18 (47.3) |
| CD4 count <200 cells/μL | 2 (5.2) |
| CD4 count unknown | 18 (47.3) |
| Eczema/psoriasis | 13 (11.5) |
| Heart disease | n ≤ 10 (3.5) |
| Diabetes | n ≤ 10 (1.8) |
| Cancer | n ≤ 10 (1.8) |
| Demographics and Comorbidities . | N = 115 . |
|---|---|
| Age, y, median (IQR) | 36 (29–42) |
| Race/ethnicity, No. (%) | |
| Non-Hispanic White | 58 (50.4) |
| Hispanic/Latinx | 26 (22.6) |
| Multiple races | 17 (14.8) |
| Black or African American | n ≤ 10 (7.8) |
| Asian or South Asian | n ≤ 10 (4.3) |
| Education. No. (%) | |
| Less than high school | n ≤ 10 (0.9) |
| High school diploma | 14 (12.2) |
| Trade school certificate | n ≤ 10 (7.0) |
| Community college or university degree | 63 (54.8) |
| Graduate degree | 25 (21.7) |
| Other | n ≤ 10 (3.5) |
| Gender, No. (%) | |
| Cisgender male | 103 (89.6) |
| Gender diverseb | 12 (10.4) |
| Sexual partners (not mutually exclusive), No. (%) | |
| Cisgender male | 110 (95.7) |
| Transgender male | 12 (10.4) |
| Nonbinary/genderqueer | 10 (8.7) |
| Cisgender female | n ≤ 10 (5.2) |
| Transgender female | n ≤ 10 (4.3) |
| Other | n ≤ 10 (3.5) |
| Comorbidities, No. (%) | |
| None of the below comorbidities | 53 (46.9) |
| HIV | 38 (33.6) |
| CD4 count ≥200 cells/μL | 18 (47.3) |
| CD4 count <200 cells/μL | 2 (5.2) |
| CD4 count unknown | 18 (47.3) |
| Eczema/psoriasis | 13 (11.5) |
| Heart disease | n ≤ 10 (3.5) |
| Diabetes | n ≤ 10 (1.8) |
| Cancer | n ≤ 10 (1.8) |
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range.
aSmall cell sizes ≤10 are suppressed.
bGender diverse includes nonbinary/genderqueer, transgender men and women, and other.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
